Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 1
2006 2
2008 1
2009 2
2010 4
2011 2
2012 3
2013 4
2014 13
2015 10
2016 19
2017 18
2018 8
2019 11
2020 15
2021 16
2022 21
2023 16
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.
Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett JL, Cree BAC, De Sèze J, Fujihara K, Kim HJ, Hornby R, Huda S, Kissani N, Kleiter I, Kuwabara S, Lana-Peixoto M, Law L, Leite MI, Pandit L, Pittock SJ, Quan C, Ramanathan S, Rotstein D, Saiz A, Sato DK, Vaknin-Dembinsky A. Paul F, et al. Among authors: quan c. Neurol Neuroimmunol Neuroinflamm. 2023 May 31;10(4):e200124. doi: 10.1212/NXI.0000000000200124. Print 2023 Jul. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37258412 Free PMC article.
The androgen receptor in bladder cancer.
Chen J, Huang CP, Quan C, Zu X, Ou Z, Tsai YC, Messing E, Yeh S, Chang C. Chen J, et al. Among authors: quan c. Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18. Nat Rev Urol. 2023. PMID: 37072491 Review.
N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target.
Quan C, Belaydi O, Hu J, Li H, Yu A, Liu P, Yi Z, Qiu D, Ren W, Ma H, Gong G, Ou Z, Chen M, Sun Y, Chen J, Zu X. Quan C, et al. Front Immunol. 2021 Aug 30;12:697026. doi: 10.3389/fimmu.2021.697026. eCollection 2021. Front Immunol. 2021. PMID: 34526985 Free PMC article. Review.
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.
Abboud H, Salazar-Camelo A, George N, Planchon SM, Matiello M, Mealy MA, Goodman A; On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium. Abboud H, et al. J Neurol. 2022 Apr;269(4):1786-1801. doi: 10.1007/s00415-021-10783-4. Epub 2021 Sep 5. J Neurol. 2022. PMID: 34482456 Free PMC article. Review.
Characterization of tau binding by gosuranemab.
Sopko R, Golonzhka O, Arndt J, Quan C, Czerkowicz J, Cameron A, Smith B, Murugesan Y, Gibbons G, Kim SJ, Trojanowski JQ, Lee VMY, Brunden KR, Graham DL, Weinreb PH, Hering H. Sopko R, et al. Among authors: quan c. Neurobiol Dis. 2020 Dec;146:105120. doi: 10.1016/j.nbd.2020.105120. Epub 2020 Sep 28. Neurobiol Dis. 2020. PMID: 32991997 Free article.
151 results